Research Article

Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial

Table 4

Comparison of OS (months).

EventsMedian0.95 LCL0.95 UCL

Control group (n = 22)1427.120.7NA
Study group (n = 22)7NANANA
HR (95% CI)2.56 (1.081–6.06)
0.035